Dapsone (4,4'-diaminodiphenylsulfone [DDS]) was administered intravenously to anesthetized dogs; urine was collected, heparinized venous blood was obtained, and bile was collected from some of the dogs. A constant infusion of inulin was maintained, and isosmotic or hypoosmotic fluids were administered. Dogs were studied under conditions of standardized, increased or decreased urine flow, and before and after plasmapheresis. Plasma, urine, and bile samples were analyzed for DDS and DDS conjugates; the degree of binding of DDS by plasma proteins was also determined. The renal clearances of inulin and DDS were calculated. No monoacetyldapsone (MADDS) was detected in the plasma, and only negligible quantities were found in the urine. Small quantities of DDS and DDS conjugates were detected in the bile in 4 h following the dose. Between 10 and 30% of the administered drug could be identified as DDS plus DDS conjugates in the urine in 8 h after the dose. Renal clearance of unbound DDS was proportional to the urine flow rate, and the clearance ratio of DDS to inulin approached the same maximal value as that for urea. Although the rate of urinary excretion of DDS conjugates was the same in the dog as in man, the rates of excretion of DDS and of DDS plus DDS conjugates were greater in the dog than in man, suggesting that the acetylation of DDS to MADDS by man but not by the dog and the greater degree of plasma protein binding of DDS and MADDS by man account for the longer half-time of disappearance of DDS in man compared to that in the dog.
acetylated metabolite (4-amino-4'-acetamidodiphenylsulfone, MADDS) are strongly bound by plasma proteins. MADDS represented 52% of the total of plasma DDS plus MADDS among nine rapid acetylators of isoniazid and sulfamethazine, whereas the corresponding value for 10 slow acetylators of these drugs was 17% (4) . The t½ of DDS from the plasma averaged 29 h (range 16 to 53 h) for 31 rapid acetylators and 28 h (range 14 to 38 h) among eight slow acetylators of the drug (17) . No differences were noted between rapid and slow acetylators in the excretion of DDS, MADDS, DDS, and MADDS produced by mild acid hydrolysis (acid-labile DDS and MADDS), and DDS resulting from strong acid hydrolysis (acid-hydrolyzable or total DDS) I Present address: Dept. of Psychiatry, Washington University School of Medicine, St. Louis, Mo. 63117. (4) . DDS was found to be 70 to 81% and MADDS 97 to 100% bound by the plasma proteins of four rapid and six slow acetylators of DDS, and the degree of binding did not appear to be related to the acetylator phenotype (2) . Finally, a study of the binding of DDS and MADDS to human serum albumin (18) showed the binding constant of MADDS to be quite large (2.35 x 105 liters/ mol), about 10 times larger than that of DDS. Another study reported MADDS to be 20 to 25 times more tightly bound than was DDS (5) .
A survey of other mammalian species demonstrated that, whereas DDS is extensively bound by the plasma proteins of all species studied (1), the t½ of DDS from the plasma varies greatly among these species, from 1 to 3 h in rabbits (6) and mice (9) , and 5 to 7 h in rats (10) , to 9 to 16 h in the dog (15) .
Drugs such as isoniazid and certain sulfonamides, acetylated polymorphically both by man (13) and the rabbit (6), are not acetylated by the dog (12, 23) . In earlier studies, no evidence of acetylation of DDS by the dog was found (14, 15) . This fact, together with the greater ease of performing a variety of investigative procedures in the dog, suggested that the renal and biliary disposition of the drug might be more easily studied in the dog than in man or in smaller species. We have carried out a number of experiments designed to elucidate the relationships among the plasma concentration of DDS, the degree of binding of DDS by plasma proteins, and the urinary and biliary excretion of DDS and its conjugates.
MATERIALS AND METHODS
The DDS and MADDS used in these studies were described previously (4) . Analyses for DDS, MADDS, and total DDS were carried out by a fluorometric procedure (16) . A more sensitive chromatographicfluorometric method (11) was applied to some samples of plasma and urine in an attempt to measure MADDS at levels undetectable by the fluorometric procedure. Measurement of the binding of DDS by the plasma proteins was performed by means of the ultrafiltration method previously described (2) . Plasma proteins were determined by a spectrophotometric method (22) ; plasma and urinary inulin levels were measured by the method of Higashi and Peters (7) .
All of the studies of renal disposition were performed in 12 adult female mongrel dogs ranging in weight from 13 to 21 kg during intravenous (i.v.) sodium pentobarbital anesthesia. Each dog was studied only once. After a femoral artery and vein had been cannulated and a retention catheter had been placed in the urinary bladder, DDS, dissolved in 50% polyethylene glycol (molecular weight 190 to 210), was administered i.v. in a dose of 25 mg/kg. Hour-long collections of urine were made, and heparinized blood samples were obtained at the midpoint of each urine collection. Varying volumes of Ringers-acetate and 0.9% NaCl solutions were adminstered i.v. to control urine flow and to hold the urine pH constant. Urine pH ranged from 6.2 to 8.5, and the pH of 70% of 108 1-h urine collections fell between 7 and 8. The administration of i.v. fluids to dogs E, F, G, and H was adjusted to maintain a urine flow rate of about 0.25 ml/min per kg for an 8-h period. After an initial 3-h period of study, dogs I, J, K, and L were subjected to plasmapheresis by the exchange of 10 250-ml portions of a 40% suspension of dog erythrocytes in 0.9% NaCl for the same number of 250-ml portions of blood. At the end of the plasmapheresis, which occupied about 3 h, a supplemental i.v. dose of DDS (1.9 to 4.6 mg/kg) was administered, and these animals were studied for an additional 3-h period. Large quantities of 0.45% NaCl were administered to dogs M and N, studied for periods of 8 h, to obtain urine flow rates approaching 1 ml/min per kg. The quantities of i.v. fluids administered to dogs 0 and P, studied only 4 
RESULTS
The results obtained with four dogs under standardized conditions of urine flow, that is, the rate of i.v. administration of isomotic fluids was adjusted to obtain a urine flow rate of about 0.25 ml/min per kg, are presented in Table 1 . For each hour-long collection period, the mean plasma DDS concentration at the midpoint of the collection period is shown, as is the mean concentration of unbound DDS, calculated from the percentage of DDS bound by plasma proteins and the concentration of DDS in those specimens. The mean rate of urine flow during each collection period is shown, together with the mean quantities of DDS and DDS conjugates present in the urine specimens. Finally, the mean clearances of DDS and inulin, and the mean ratio of these clearances are shown for each collection period. These data show that the mean ratio of DDS clearance to inulin clearance varied between 0.25 and 0.47 with a grand mean of 0.32; individual ratios varied between 0.15 and 0.60.
Four dogs were studied both before and after plasmapheresis, also under standardized conditions of urine flow, to measure the effects of decreased plasma protein binding of DDS. (Table 3) . A mean urine flow rate of 0.92 ml/min per kg was achieved during the first 6 h of these studies; by contrast, the mean urine flow rate for dogs E, F, G, and H (Table 1) studied for 8 h, and for dogs I, J, K and L (Table   2 ) studied for 6 h was 0.24 ml/min per kg. The mean clearance ratio for the first 6 h of study of dogs M and N was 0.52, a value significantly larger than the mean of 0.32 for the four animals studied under standardized conditions of urine flow. During the last 2 h of the studies of dogs M and N, the rate of i.v. fluid administration was deliberately reduced to decrease the rate of urine flow; the reduction of the urine flow rate was accompanied by a decrease of the clearance ratio to 0.27 during the 8th h. Dogs 0 and P were studied while i.v. fluid administration was greatly restricted to decrease the urine flow rate. Table 4 shows that the mean urine flow rate during the first 3 h was only 0.04 ml/min per kg. The mean clearance ratio during this period was 0.14, significantly smaller than the mean clearance ratio of 0.32 obtained under standardized conditions of urine flow. During the 4th h, the rate of i.v. fluid administration was deliberately increased to achieve a higher rate of urine flow; the mean urine flow rate of 0.23 ml/min per kg was accompanied by a mean clearance ratio of 0.30. The impression that the clearance ratio of DDS to inulin (CDD0;/C1n) increased with an increase in the rate of urine flow was confirmed by a plot of the clearance ratio as a function of the urine flow rate (Fig. 1) . The points representing 77-h-long clearance periods appear to fit reasonably well the exponential: (i) CDDS/CIC, = 0.60e0°ll/v, in which v is the urine flow rate in milliliters per minute per kilogram. A relationship of this form was suggested by Dole (3) to describe the dependence of urea clearance on the rate of urine flow. Thus, as the rate of urine flow approaches the glomerular filtration rate (i.e., the inulin clearance), the clearance ratio approaches 0.60.
The data of Tables 1 and 3 show that the contribution of DDS to total DDS averaged 57% in the six 8-h studies. Because of this large contribution of DDS to total urinary DDS and the dependence of the renal clearance of DDS on the urine flow rate, the rate of excretion of total DDS may also be expected to depend on the urine flow rate. The data of Tables 1-4 permit an analysis of the relationships between urinary flow rate and the rate of urinary excretion of DDS, total DDS, and DDS conjugates. conjugates are described in Table 5 , in which the dogs are arranged by urine flow rate. The values shown for urine flow rate and urinary excretory rates are the individual means of 6 h study of dogs E, F, G, H, M, and N, and of 3 h study of dogs 0 and P and of dogs I, J, K, and L before plasmapheresis. The relationships between the urinary excretory rates and the urine flow rate may be analyzed by testing the fit of each relationship to an exponential of the form of equation (i), calculated from the regression of the natural logarithm of the urinary excretory aThe values shown are the means for 6 h for dogs E, F, G, H, M and N, and for only 3 In each case, the numerator of the exponent (the slope of the regression line) is significantly different from 0 at the 95% level of confidence. Therefore, as expected from the dependence of the renal clearance of DDS on the urine flow rate and the large contribution of DDS to urinary total DDS, the rate of excretion of total DDS clearly depends on the urine flow rate. It is surprising to find that the rate of excretion of DDS conjugates is also related to the urine flow rate.
The availability of quantities of plasma and urine from dogs to which a large dose of DDS had been administered presented an opportunity to examine further the question of whether the dog is capable of acetylating DDS. Thirteen plasma samples obtained after the administration of 25 mg of DDS per kg were reanalyzed by the chromatographic-fluorometric procedure (12) . The concentration of DDS in these samples ranged from 3.8 to 13,ug/ml; less than 0.005 ,ug of MADDS per ml was detected in these samples. Sixteen samples of urine obtained after the administration of 25 mg of DDS per kg were also reanalyzed for DDS and MADDS; although the concentration of DDS in these samples ranged from 5.9 to 34 jig/ml, less than 0.005 ,ug of MADDS per ml could be detected.
Eight of these samples were also analyzed after hydrolysis in normal HCl for 1 h at room temperature. The concentration of DDS ranged for 13 to 61 ,ug/ml; 0.004 to 0.016 ,ug of MADDS per ml was found by extracting the hydrolyzed samples with dichloroethane, subjecting the extracts to thin-layer chromatography on silica gel by using ethyl acetate as the solvent, extracting the spots corresponding to MADDS with ethyl acetate, and assaying these extracts by the chromatographic-fluorometric procedure. In none of these specimens was the quantity of MADDS as great as 0.05% that of the DDS present.
The results of the study of biliary excretion of DDS and its conjugates in four dogs are summarized in Table 6 . During 4-h periods of study, only 0.5 to 1.2% of the dose could be accounted for in the bile of the dogs as total DDS, whereas 4.9 to 10.4% of the dose appeared in the urine as total DDS during this time; unchanged DDS accounted for more than 50% of the total DDS present in the urine, and only 3 to 8% of the total DDS found in the bile. No MADDS could be detected in the plasma, bile, or urine. Dogs Q and T were each studied for a subsequent 4-h perind without an additional dose of DDS. The results of these additional studies were very much the same as those of the first 4-h studies. DISCUSSION Dole (3) has shown both in man and in the dog that the ratio of urea clearance to that of inulin bears an exponential relationship to the rate of urine flow. The dependence of the renal clearance of DDS on the rate of urine flow suggests that this drug is handled in the renal tubule in a manner analogous to that by which urea is handled. The pK, of DDS is 13; even at the lowest urinary pH values encountered, therefore, DDS is present almost entirely in its un-ionized form, and could diffuse passively across the renal tubular epithelium. Indeed, as the urine flow rate approaches the glomerular filtration rate, the clearance of DDS approaches the same maximal value as does that of urea, probably because of decreased tubular reabsorption.
An average of 26% of the dose of DDS was excreted in the urine as total DDS during the first 8 h after administration to six dogs; excretion of unchanged DDS accounted for an average of 14% of the dose. Similar data are available from studies in man. In Table 7 are listed the quantities of DDS and of total DDS excreted into the urine of nine human volunteers during the first 12 h after an oral dose of 100 mg of DDS: these 12-h specimens represent fractions of urine collections obtained over longer periods of time (4) . Whereas about 50% of the total DDS in the urine of the dog is unchanged DDS, less than 20% of the total DDS (sum of DDS plus DDS conjugates) is present as DDS in the urine of human subjects. On the other hand, the nine subjects excreted almost 13% of the dose as DDS conjugates during the first 12 h after the dose; the dogs also excreted about 13% of the dose in this form during the first 8 h after DDS administration. Thus, the fraction of the dose excreted in the urine as DDS is considerably larger in the dog than in man, whereas the fraction appearing as DDS conjugates is about the same in the two species. Because the watersoluble conjugates should be readily cleared by the kidney, the similarity of the fraction of administered DDS appearing as conjugates in the urine suggests that the rates of formation of VOL. 7, 1975 on October 25, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER. Two alternative explanations must be considered. First, it is obvious that the rate of urine flow, upon which the rate of excretion of unchanged DDS depends (Fig. 1) 70-kg man who produces 2,000 ml of urine in a 24-h period has a urine flow rate much smaller than that of any of the dogs described in this report. Thus, differences of the rate of urine flow may also account, at least in part, for the difference of t½ between species.
Second, as expected from the small molecular weight of DDS (20) , very little of this compound was excreted into the bile of the dog. Perhaps because the DDS conjugates are larger molecules, these were excreted into the bile more readily. The importance of the biliary route of excretion of DDS and its conjugates in the bodily economy of DDS of the dog may be assessed by a consideration of the ratio of biliary total DDS to urinary total DDS. In the four dogs, the quantity of total DDS excreted into the bile represented only 6 to 15% of that excreted into the urine during the same period of time. The study of biliary excretion of DDS and its conjugates in three patients undergoing T-tube drainage of the common bile duct after cholecystectomy has yielded similar results (J. T. Biggs, and L. Levy, unpublished data). This study showed that from 0.44 to 1.6% of the dose was found as total DDS in the bile during the 24 h after a 50-mg dose of DDS by mouth; 23 to 42% of the dose could be accounted for as DDS, MADDS, and their conjugates in the urine of these patients collected during the same period of time. The ratio of biliary to urinary total DDS ranged from 1 to 6%. Although some fraction of the dose may have been excreted into the bile as metabolites of DDS not measured as total DDS, it does not appear likely that the biliary excretion and subsequent reabsorption from the small intestine of DDS and its conjugates could play an important role in slowing the disappearance of DDS from the plasma of both man and the dog.
We previously showed that, on the average, four human subjects excreted only 60% of the dose of DDS into the urine as total DDS during a period of 120 h (4). Therefore, an important fraction of the dose is undoubtedly transformed and excreted into both the urine and bile as compounds that do not yield DDS on strong acid hydrolysis. It may be that the activity of some alternative pathways of metabolism and elimination of DDS, e.g., the formation and excretion of N-hydroxy (8, 21) or ring-hydroxylated derivatives of DDS, differs greatly between the dog and man.
